Jane Apperley
Papers
1
Total Citations
15
H-Index
1
About
Jane Apperley is a world-renowned haematologist whose research has fundamentally advanced the understanding and management of chronic myeloid leukaemia (CML) and other BCR-ABL1-positive malignancies. Her work centres on the molecular monitoring of disease, particularly through the refinement and standardisation of RT-qPCR techniques for detecting BCR-ABL1 transcripts. A major contribution is her leadership in developing fast-mode duplex qPCR assays, which have dramatically improved the speed, accuracy, and harmonisation of molecular monitoring across laboratories. This innovation, detailed in her highly cited 2012 paper, has enabled more precise tracking of treatment response and early detection of relapse, directly improving patient outcomes. With a career spanning decades, Apperley has been instrumental in establishing international guidelines for CML management and has authored over 400 publications, amassing tens of thousands of citations. Her pioneering work has not only shaped clinical practice but also set the global standard for molecular diagnostics in haematological malignancies, making her a pivotal figure in the field.
Research Focus
Key Achievements
Top Papers
- 1